Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-16

Celcuity Inc. (CELC) Stock Forecast Oct. 16, 2026

Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq

Follow Unlock full AI forecasts
Rating · 90D ▲ Bullish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Top 35% of 5184 stocks scored
Rank correlation · 90D 17.0% Spearman, 357 dates
Market Cap $2.77B mid-cap · #11 of 29 peers
Summary

Celcuity Inc. (CELC) stock forecast summary

Our AI ranks Celcuity Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Celcuity Inc. is a mid-cap company with a market capitalization of $2.77B. It ranks number 11 by market capitalization among the 29 Services-Medical Laboratories issuers in our coverage with a current forecast.

For CELC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 17.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 6.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, CELC included.

Follow CELC free
Price

CELC price chart and AI forecast

CELC
Cross-section · 2026-10-16

How CELC ranks among 5184 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-06-30

Celcuity Inc. (CELC) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Medical Laboratories peers listed below that report each metric.

Valuation & Market

MetricCELCIndustry medianRank
Market Cap $2.77B $1.04B 11/29
EPS $-4.19 – –
FCF/Share $-3.93 – –

Profitability & Margins

MetricCELCIndustry medianRank
ROA -27.4% -10.8% 13/20
ROIC -28.1% -12.9% 19/24

Financial Health

MetricCELCIndustry medianRank
Current Ratio 8.93x 3.61x 5/26
Interest Coverage -18.9x -16.6x 13/23
Working Capital $689M $242M 7/26

Cash Flow

MetricCELCIndustry medianRank
Operating Cash Flow -$192M -$910K 26/27
Free Cash Flow -$192M -$490K 15/17
Capital Spending -$450K -$17M 2/17

Income Statement

MetricCELCIndustry medianRank
Operating Income -$209M -$11M 23/26
Net Income -$226M -$20M 18/20
R&D Expense $137M $56M 5/20

Dividend & Shareholder Information

MetricCELCIndustry medianRank
Shares Outstanding 49M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$776M
Cash & Short-term Investments$182M
Total Liabilities$841M
Short-term Debt$79M
Quarterly Financial Reports

CELC quarterly financials and insider trading

Industry Peers · Services-Medical Laboratories

Celcuity Inc. (CELC) industry peers

Companies classified under the same SEC industry code as Celcuity Inc. (Services-Medical Laboratories): 30 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
CELC Celcuity Inc. ▲ $2.77B – –
NTRA Natera, Inc. ▲ $56.71B – 31.1x
DGX Quest Diagnostics Inc ▼ $25.94B 25.0x 3.5x
LH Labcorp Holdings Inc. ▶ $25.79B 26.3x 3.0x
GH Guardant Health, Inc. ▲ $21.28B – –
CAI Caris Life Sciences, Inc. ▲ $8.64B 6.4x 14.6x
RDNT Radnet, Inc. ▶ $5.41B – 4.9x
GRAL Grail, Inc. ▲ $5.26B – 2.1x
BLLN Billiontoone, Inc. ▲ $4.63B 338.3x –
VCYT Veracyte, Inc. ▲ $3.47B 37.8x 2.5x
CDNA Caredx, Inc. ▲ $3.31B 35.0x 7.8x
FTRE Fortrea Holdings Inc. ▶ $2.14B – 4.1x
PSNL Personalis, Inc. ▼ $1.67B – 7.1x
FRNM Freenome, Inc. ▶ $1.26B – –
LMRI Lumexa Imaging Holdings, Inc. ▶ $1.04B – 1.7x
CSTL Castle Biosciences Inc ▲ $976M – 2.1x
FLGT Fulgent Genetics, Inc. ▲ $545M – 0.5x
BDSX Biodesix Inc ▲ $250M – 27.3x
XGN Exagen Inc. ▲ $187M – 15.3x
BNR Burning Rock Biotech Ltd ▲ $139M – 2.4x
SERA Sera Prognostics, Inc. ▼ $80M – 1.3x
CFOR Capforce Inc. ▶ $43M – 0.6x
MDXH Mdxhealth Sa ▲ $20M – –
AMS American Shared Hospital Services ▼ $9M – 0.4x
ADVB Advanced Biomed Inc. ▶ $7M – 0.7x
ACON Aclarion, Inc. ▲ $5M – 0.3x
BGLC Bionexus Gene Lab Corp ▲ $4M – 0.5x
LUDG Ludwig Enterprises, Inc. ▼ $670K – –
FCHS First Choice Healthcare Solutions, Inc. ▶ $260K – –
RNLXY Renalytix Plc ▲ N/A – –

Where CELC sits on the market map

Industrial Applications and Services · Services-Medical Laboratories
Explore the map →
News

Celcuity Inc. (CELC) stock news

Loading...

FAQ

Celcuity Inc. (CELC) stock forecast FAQ

What is the Celcuity Inc. (CELC) stock forecast?

Our AI ranks Celcuity Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Celcuity Inc. stock predictions?

For CELC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 17.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 6.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Celcuity Inc. forecasts updated?

Celcuity Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.

Which companies are Celcuity Inc.'s industry peers?

30 issuers in our coverage, CELC included, share the SEC industry code Services-Medical Laboratories. The largest are: Natera, Inc. (NTRA), Quest Diagnostics Inc (DGX), Labcorp Holdings Inc. (LH), Guardant Health, Inc. (GH), Caris Life Sciences, Inc. (CAI), Radnet, Inc. (RDNT).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.